Arcus Biosciences
RCUS
RCUS
148 hedge funds and large institutions have $1.25B invested in Arcus Biosciences in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 53 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 53
5.57% less ownership
Funds ownership: 68.69% → 63.12% (-5.6%)
76% less call options, than puts
Call options by funds: $3.19M | Put options by funds: $13.1M
Holders
148
Holding in Top 10
5
Calls
$3.19M
Puts
$13.1M
Top Buyers
| 1 | +$34.8M | |
| 2 | +$15.1M | |
| 3 | +$11.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.62M |
| 5 |
Renaissance Technologies
New York
|
+$7.21M |
Top Sellers
| 1 | -$24.6M | |
| 2 | -$16.1M | |
| 3 | -$10.6M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$10.1M |
| 5 |
AI
Alphabet Inc
Mountain View,
California
|
-$9.17M |